MediWound Ltd. Signed A Scale-Up Agreement With Biopharmax Group Ltd. To Establish A State-Of-The-Art Manufacturing Facility And Increase Production Capacity To Meet The Growing Global Demand For Nexobrid; Estimated $12M Will Be Invested In The Pro
Portfolio Pulse from Happy Mohamed
MediWound Ltd. has signed a scale-up agreement with Biopharmax Group Ltd. to establish a state-of-the-art manufacturing facility and increase production capacity to meet the growing global demand for Nexobrid. An estimated $12M will be invested in the project.
July 17, 2023 | 8:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
MediWound's partnership with Biopharmax to increase Nexobrid production could potentially boost its revenues and profitability.
The agreement with Biopharmax will allow MediWound to increase the production of Nexobrid, which could lead to increased sales and revenues. The $12M investment in the project also indicates a significant commitment to the product's success.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100